Nonalcoholic fatty liver disease markers are associated with insulin resistance in type 1 diabetes. (Q51550409)

6 April 2018

title

Nonalcoholic fatty liver disease markers are associated with insulin resistance in type 1 diabetes. (English)

1 reference

6 April 2018

metabolic dysfunction–associated steatotic liver disease

0 references

1 reference

1 reference

1 reference

1 reference

Tomislav Bulum

1

1 reference

6 April 2018

Branko Kolarić

series ordinal

2

1 reference

6 April 2018

Lea Duvnjak

series ordinal

3

1 reference

6 April 2018

Marko Duvnjak

series ordinal

4

1 reference

6 April 2018

publication date

7 July 2011

1 reference

6 April 2018

Digestive Diseases and Sciences

published in

1 reference

6 April 2018

volume

56

1 reference

6 April 2018

issue

12

1 reference

6 April 2018

page(s)

3655-3663

1 reference

6 April 2018

https://scigraph.springernature.com/pub.10.1007/s10620-011-1807-7

exact match

0 references

cites work

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1807-7

Can clinical factors estimate insulin resistance in type 1 diabetes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1807-7

Insulin resistance, the metabolic syndrome, and complication risk in type 1 diabetes: "double diabetes" in the Diabetes Control and Complications Trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1807-7

21 January 2018

The metabolic syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1807-7

Non-alcoholic fatty liver disease: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1807-7

Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1807-7

Nonalcoholic steatohepatitis. Clinicopathological comparison with alcoholic hepatitis in ambulatory and hospitalized patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1807-7

Hepatic metabolism of insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1807-7

Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1807-7

NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1807-7

Postprandial triglyceride-rich lipoprotein metabolism and insulin sensitivity in nonalcoholic steatohepatitis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1807-7

Liver-fat accumulation and insulin resistance in obese women with previous gestational diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1807-7

Review: The role of insulin resistance in nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1807-7

Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1807-7

High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1807-7

Nonalcoholic Steatohepatitis in Children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1807-7

Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1807-7

Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1807-7

Prevalence and risk factors of non-alcoholic fatty liver disease in potential living liver donors in Korea: a review of 589 consecutive liver biopsies in a single center

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1807-7

Association of nonalcoholic fatty liver disease with insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1807-7

Elevations in markers of liver injury and risk of type 2 diabetes: the insulin resistance atherosclerosis study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1807-7

Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1807-7

Alanine aminotransferase, gamma-glutamyltransferase, and incident diabetes: the British Women's Heart and Health Study and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1807-7

Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1807-7

Long-term follow-up of patients with NAFLD and elevated liver enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1807-7

Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1807-7

Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1807-7

Banting lecture 1988. Role of insulin resistance in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1807-7

Fatty liver in type 2 diabetes mellitus: relation to regional adiposity, fatty acids, and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1807-7

Regulation of gene expression by insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1807-7

Metformin in non-alcoholic steatohepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1807-7

A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1807-7

Insulin resistance in insulin-dependent diabetic patients with microalbuminuria

21 January 2018

1 reference

12 December 2020

Cardiovascular morbidity and mortality associated with the metabolic syndrome

1 reference

12 December 2020

Insulin resistance, the metabolic syndrome, and nonalcoholic fatty liver disease

1 reference

12 December 2020

The relationship of acute insulin sensitivity to the progression of vascular disease in long-term type 1 (insulin-dependent) diabetes mellitus

1 reference

12 December 2020

Nonalcoholic steatohepatitis: An expanded clinical entity

1 reference

12 December 2020

The prevalence and etiology of elevated aminotransferase levels in the United States

1 reference

12 December 2020

Serum gamma-glutamyltransferase and development of impaired fasting glucose or type 2 diabetes in middle-aged Japanese men.

1 reference

12 December 2020

Evaluation and management of non-alcoholic steatohepatitis

1 reference

12 December 2020

Serum ferritin as a component of the insulin resistance syndrome

1 reference

12 December 2020

Alcohollike liver disease in nonalcoholics. A clinical and histologic comparison with alcohol-induced liver injury

1 reference

12 December 2020

Nonalcoholic steatohepatitis (NASH) with diabetes: predictors of liver fibrosis.

1 reference

12 December 2020

Insulin resistance is a prominent feature of insulin-dependent diabetes

1 reference

12 December 2020

Nonalcoholic fatty liver disease: a feature of the metabolic syndrome

1 reference

12 December 2020

Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men.

1 reference

12 December 2020

Banting lecture 1988. Role of insulin resistance in human disease

1 reference

12 December 2020

Usefulness of a combined evaluation of the serum adiponectin level, HOMA-IR, and serum type IV collagen 7S level to predict the early stage of nonalcoholic steatohepatitis

1 reference

12 December 2020

Non-alcoholic fatty liver disease

1 reference

12 December 2020

Prevalence and prognostic implications of the metabolic syndrome in community-based patients with type 1 diabetes: The Fremantle Diabetes Study

1 reference

12 December 2020

Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction

1 reference

12 December 2020

10.1007/S10620-011-1807-7

Identifiers

DOI

1 reference

6 April 2018

PubMed ID

21735081

1 reference

6 April 2018